The role of activin A and Akt/GSK signaling in ovarian tumor biology

Endocrinology

Volumn 149, Issue 8, 2008, Pages 3809-3816

  Do, Thuy Vy ^a,b   Kubba, Lena A ^a,c   Antenos, Monica ^a,b   Rademaker, Alfred W ^a   Sturgis, Charles D ^a,c   Woodruff, Teresa K ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Northwestern University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; GLYCOGEN SYNTHASE KINASE; PROTEIN KINASE B; PROTEIN SUBUNIT;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYSTADENOMA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MITOSIS; MOLECULAR DYNAMICS; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STROMA CELL; TISSUE MICROARRAY; TUMOR LOCALIZATION;

ACTIVINS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL PROLIFERATION; CYSTADENOCARCINOMA, SEROUS; CYSTADENOMA, SEROUS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PHOSPHORYLATION; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 47949107815     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1584     Document Type: Article

References (49)

1. Leung PC, Choi JH 2007 Endocrine signaling in ovarian surface epithelium and cancer. Hum Reprod Update 13:143-162
2. Mok SC, Elias KM, Wong KK, Ho K, Bonome T, Birrer MJ 2007 Biomarker discovery in epithelial ovarian cancer by genomic approaches. Adv Cancer Res 96:1-22
3. Bast Jr RC, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, Lu K, Lu Z, Badgwell D, Mills GB, Skates S, Zhang Z, Chan D, Lokshin A, Yu Y 2007 Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res 174:91-100
4. Cvetkovic D 2003 Early events in ovarian oncogenesis. Reprod Biol Endocrinol 1:68
5. Bast Jr RC 2003 Status of tumor markers in ovarian cancer screening. J Clin Oncol 21(Suppl):200s-205s
6. Seidman JD, Russel P, Kurman RJ 2002 Surface epithelial tumors of the ovary. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. 5th ed. New York: Springer-Verlag; 791-904
7. Scully RE 1999 World Health Organization international histological classification of tumors. 2nd ed. New York: Springer
8. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC 2001 Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255-288
9. Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H 1997 Expression of E-cadherin and N-cadherin in surface epithelialstromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol 28:734-739
10. Wong AS, Maines-Bandiera SL, Rosen B, Wheelock MJ, Johnson KR, Leung PC, Roskelley CD, Auersperg N 1999 Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer 81:180-188
11. Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A, Roskelley CD 1999 E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 96:6249-6254
12. Dupont J, McNeilly J, Vaiman A, Canepa S, Combarnous Y, Taragnat C 2003 Activin signaling pathways in ovine pituitary and LβT2 gonadotrope cells. Biol Reprod 68:1877-1887
13. Peng C 2003 The TGF-β superfamily and its roles in the human ovary and placenta. J Obstet Gynaecol Can 25:834-844
14. Zhang L, Deng M, Parthasarathy R, Wang L, Mongan M, Molkentin JD, Zheng Y, Xia Y 2005 MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 25:60-65
15. Thompson TB, Cook RW, Chapman SC, Jardetzky TS, Woodruff TK 2004 βA versus βB: is it merely a matter of expression? Mol Cell Endocrinol 225:9-17
16. Pangas SA, Woodruff TK 2000 Activin signal transduction pathways. Trends Endocrinol Metab 11:309-314
17. Choi KC, Kang SK, Nathwani PS, Cheng KW, Auersperg N, Leung PC 2001 Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE). Mol Cell Endocrinol 174:99-110
18. Petraglia F, Sacerdote P, Cossarizza A, Angioni S, Genazzani AD, Franceschi C, Muscettola M, Grasso G 1991 Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-- production. J Clin Endocrinol Metab 72:496-502
19. Olsson N, Piek E, ten Dijke P, Nilsson G 2000 Human mast cell migration in response to members of the transforming growth factor-β family. J Leukoc Biol 67:350-356
20. Hyuga S, Kawasaki N, Hashimoto O, Hyuga M, Ohta M, Yamagata S, Yamagata T, Hayakawa T 2000 Possible role of hepatocyte growth factor/scatter factor and activin A produced by the target organ in liver metastasis. Cancer Lett 153:137-143
21. Ogawa K, Funaba M, Mathews LS, Mizutani T 2000 Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages. J Immunol 165:2997-3003
22. Jones RL, Findlay JK, Farnworth PG, Robertson DM, Wallace E, Salamonsen LA 2006 Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 147:724-732
23. Steller MD, Shaw TJ, Vanderhyden BC, Ethier JF 2005 Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells. Mol Cancer Res 3:50-61
24. Menon U, Riley SC, Thomas J, Bose C, Dawnay A, Evans LW, Groome NP, Jacobs IJ 2000 Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma. BJOG 107:1069-1074
25. Chudecka-Glaz A, Rzepka-Gorska I 2005 Activin A levels in serum and cyst fluid in epithelial tumors of the ovary. Int J Gynaecol Obstet 89:160-162
26. Cobellis L, Reis FM, Luisi S, Danero S, Pirtoli L, Scambia G, Petraglia F 2004 High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer. J Soc Gynecol Investig 11:203-206
27. Mabuchi Y, Yamoto M, Minami S, Umesaki N 2006 The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells. Oncol Rep 16: 373-379
28. Tanaka T, Toujima S, Umesaki N 2004 Growth-inhibitory signals by activin A do not affect anticancer drug-sensitivity and acquired multi-drug-resistance in human ovarian endometrioid adenocarcinoma OVK-18 cells. Oncol Rep 11:667-671
29. Tanaka T, Toujima S, Umesaki N 2004 Activin A inhibits growth-inhibitory signals by TGF-β1 in differentiated human endometrial adenocarcinoma cells. Oncol Rep 11:875-879
30. Shih IeM, Kurman RJ 2005 Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 11:7273-7279
31. Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast Jr RC, Stack MS 1994 Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int J Cancer 56:552-559
32. Lau KM, Mok SC, Ho SM 1999 Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 96:5722-5727
33. Pangas SA, Rademaker AW, Fishman DA, Woodruff TK 2002 Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J Clin Endocrinol Metab 87:2644-2657
34. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR 1992 AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 89:9267-9271
35. Wang Y, Helland A, Holm R, Kristensen GB, Borresen-Dale AL 2005 PIK3CA mutations in advanced ovarian carcinomas. Hum Mut 25:322
36. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G, Testa JR 1995 Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64:280-285
37. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW 1999 PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21:99-102
38. Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH, Thomas RJ, Phillips WA 2001 The phosphatidylinositol 3-′-kinase p85α gene is an oncogene in human ovarian and colon tumors. Cancer Res 61:7426-7429
39. Levine DA, Bogomolniy F, Yee CJ, Lash A, Barakat RR, Borgen PI, Boyd J 2005 Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res 11:2875-2878
40. van Weeren PC, de Bruyn KM, de Vries-Smits AM, van Lint J, Burgering BM 1998 Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J Biol Chem 273:13150-13156
41. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL 2000 Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-36810
42. Rosano L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A 2005 Endothelin-1 promotes epithelial-to- mesenchymal transition in human ovarian cancer cells. Cancer Res 65:11649-11657
43. Barata JT, Silva A, Brandao JG, Nadler LM, Cardoso AA, Boussiotis VA 2004 Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med 200:659-669
44. Kim YG, Kim MJ, Lim JS, Lee MS, Kim JS, Yoo YD 2006 ICAM-3-induced cancer cell proliferation through the PI3K/Akt pathway. Cancer Lett 239:103-110
45. Hideshima T, Nakamura N, Chauhan D, Anderson KC 2001 Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 20:5991-6000
46. Jiang H, Guo W, Liang X, Rao Y 2005 Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3β and its upstream regulators. Cell 120:123-135
47. Zhou FQ, Zhou J, Dedhar S, Wu YH, Snider WD 2004 NGF-induced axon growth is mediated by localized inactivation of GSK-3β and functions of the microtubule plus end binding protein APC. Neuron 42:877-879
48. Di Simone N, Crowley Jr WF, Wang QF, Sluss PM, Schneyer AL 1996 Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 137:486-494
49. Do TV, Kubba LA, Du H, Sturgis CD, Woodruff TK 2008 Transforming growth factor-β1, transforming growth factor-β2, and transforming growth factor-β3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition. Mol Cancer Res 6:695-705